Back
Aadi Bioscience Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
34
AADI
Aadi Bioscience
Last Price:
1.93
Seasonality Move:
-26.95%
Sell
42
NBY
NovaBay Pharmaceuticals
Last Price:
0.71
Seasonality Move:
-19.92%
Sell
34
Aadi Bioscience (AADI)
is a Sell
Is Aadi Bioscience a Buy, Sell or Hold?
- The current Aadi Bioscience [AADI] share price is $1.94. The Score for AADI is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- AADI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AADI Stock Price Chart
What is Aadi Bioscience's stock price today?
-
The Aadi Bioscience share price today is $1.94
The current trend is moderately bullish and AADI is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
AADI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 58.21 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.8 - 1.94) | Buy |
| Bollinger Bands (100): | (1.48 - 1.86) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 55.73 | Buy |
| Chaikin Money Flow: | -66635 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.46 - 0.7) | Buy |
| Bollinger Bands (100): | (0.33 - 3.11) | Sell |
AADI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.95 | Sell |
| 20-day SMA: | 1.89 | Buy |
| 50-day SMA: | 1.69 | Buy |
| 200-day SMA: | 1.81 | Buy |
| 8-day EMA: | 1.94 | Buy |
| 20-day EMA: | 1.88 | Buy |
| 50-day EMA: | 1.77 | Buy |
| 200-day EMA: | 2.41 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.71 | Buy |
| 20-day SMA: | 0.61 | Buy |
| 50-day SMA: | 0.55 | Buy |
| 200-day SMA: | 3.29 | Sell |
| 8-day EMA: | 0.7 | Buy |
| 20-day EMA: | 0.65 | Buy |
| 50-day EMA: | 0.87 | Sell |
| 200-day EMA: | 7.55 | Sell |
Aadi Bioscience Earnings Growth & AADI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.78 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Aadi Bioscience Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||